155 related articles for article (PubMed ID: 9844777)
1. Circulating soluble CD30 levels in primary Sjögren's syndrome, SLE and rheumatoid arthritis.
Ichikawa Y; Yoshida M; Yamada C; Horiki T; Hoshina Y; Uchiyama M
Clin Exp Rheumatol; 1998; 16(6):759-60. PubMed ID: 9844777
[No Abstract] [Full Text] [Related]
2. Soluble CD23 levels are elevated in the serum of patients with primary Sjögren's syndrome and systemic lupus erythematosus.
Bansal A; Roberts T; Hay EM; Kay R; Pumphrey RS; Wilson PB
Clin Exp Immunol; 1992 Sep; 89(3):452-5. PubMed ID: 1387597
[TBL] [Abstract][Full Text] [Related]
3. IgG antibodies from patients with primary Sjögren's syndrome and systemic lupus erythematosus recognize different epitopes in 60-kD SSA/Ro protein.
Barakat S; Meyer O; Torterotot F; Youinou P; Briand JP; Kahn MF; Muller S
Clin Exp Immunol; 1992 Jul; 89(1):38-45. PubMed ID: 1378364
[TBL] [Abstract][Full Text] [Related]
4. Sialographic study in patients with and without antibodies to Sjögren's syndrome A (Ro).
Miyachi K; Naito M; Maeno Y; Suzuki S; Hamamoto T; Sugiura M; Kasahara M; Torikai K; Umeda H
J Rheumatol; 1983 Jun; 10(3):387-94. PubMed ID: 6604159
[TBL] [Abstract][Full Text] [Related]
5. Reflections in the assessment of secondary Sjogren's syndrome.
Hernández-Molina G; Avila-Casado C; Sánchez-Guerrero J
Rheumatology (Oxford); 2011 Aug; 50(8):1519-21. PubMed ID: 21672968
[No Abstract] [Full Text] [Related]
6. Antibody to Ro in a population of patients with systemic lupus erythematosus: distribution, clinical and serological associations.
Dillon CF; Jones JV; Reichlin M
J Rheumatol; 1983 Jun; 10(3):380-6. PubMed ID: 6604158
[TBL] [Abstract][Full Text] [Related]
7. Expression of CD5 and CD23 on B cells of patients with rheumatoid arthritis, systemic lupus erythematosus and Sjögren's syndrome. Relationship with disease activity and treatment.
Ebo D; DeClerck LS; Bridts CH; Stevens WJ
In Vivo; 1994; 8(4):577-80. PubMed ID: 7534494
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies to box A of high mobility group box 1 in systemic lupus erythematosus.
Schaper F; de Leeuw K; Horst G; Maas F; Bootsma H; Heeringa P; Limburg PC; Westra J
Clin Exp Immunol; 2017 Jun; 188(3):412-419. PubMed ID: 28245520
[TBL] [Abstract][Full Text] [Related]
9. Anti-Ro(SS-A) HLA-DR3-positive women: the interrelationship between some ANA negative, SS, SCLE, and NLE mothers and SS/LE overlap female patients.
Provost TT; Watson R
J Invest Dermatol; 1993 Jan; 100(1):14S-20S. PubMed ID: 8423383
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to Sm and SS-A demonstrated by enzyme immunoassay. Correlation to clinical manifestations and disease activity in patients with systemic lupus erythematosus.
Gripenberg M; Teppo AM; Friman C
Rheumatol Int; 1991; 11(4-5):209-13. PubMed ID: 1784890
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of cartilage oligomeric matrix protein are elevated in rheumatoid arthritis, but not in inflammatory rheumatic diseases such as psoriatic arthritis, reactive arthritis, Raynaud's syndrome, scleroderma, systemic lupus erythematosus, vasculitis and Sjögren's syndrome.
Skoumal M; Haberhauer G; Feyertag J; Kittl EM; Bauer K; Dunky A
Arthritis Res Ther; 2004; 6(2):73-4. PubMed ID: 15059267
[No Abstract] [Full Text] [Related]
12. Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity.
Sellam J; Proulle V; Jüngel A; Ittah M; Miceli Richard C; Gottenberg JE; Toti F; Benessiano J; Gay S; Freyssinet JM; Mariette X
Arthritis Res Ther; 2009; 11(5):R156. PubMed ID: 19832990
[TBL] [Abstract][Full Text] [Related]
13. Rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren's syndrome shared megakaryocyte expansion in peripheral blood.
Wang Y; Xie X; Zhang C; Su M; Gao S; Wang J; Lu C; Lin Q; Lin J; Matucci-Cerinic M; Furst DE; Zhang G
Ann Rheum Dis; 2022 Mar; 81(3):379-385. PubMed ID: 34462261
[TBL] [Abstract][Full Text] [Related]
14. The molecular basis of the SSA/Ro antigens and the clinical significance of their autoantibodies.
Ben-Chetrit E
Br J Rheumatol; 1993 May; 32(5):396-402. PubMed ID: 8495261
[TBL] [Abstract][Full Text] [Related]
15. [Sjögren's disease].
Bijl M; Panders AK; Vissink A; Nikkels PG; Kallenberg CG
Ned Tijdschr Geneeskd; 1994 May; 138(21):1049-52. PubMed ID: 8202174
[No Abstract] [Full Text] [Related]
16. Raised circulating tenascin-C in rheumatoid arthritis.
Page TH; Charles PJ; Piccinini AM; Nicolaidou V; Taylor PC; Midwood KS
Arthritis Res Ther; 2012 Nov; 14(6):R260. PubMed ID: 23193984
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity and specificity of anti-alpha-fodrin antibodies in primary Sjögren's syndrome.
Szántó A; Csípo I; Zeher M
J Rheumatol; 2005 Jan; 32(1):197; author reply 197-8. PubMed ID: 15630756
[No Abstract] [Full Text] [Related]
18. Genetic studies of anti-Ro (SSA) antibodies in families with rheumatoid arthritis.
Tishler M; Moutsopoulos HM; Yaron M
J Rheumatol; 1992 Feb; 19(2):234-6. PubMed ID: 1629820
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual.
Frodlund M; Vikerfors A; Grosso G; Skogh T; Wetterö J; Elvin K; Gunnarsson I; Kastbom A; Dahlström Ö; Rönnelid J; Svenungsson E; Sjöwall C
Clin Exp Immunol; 2018 Oct; 194(1):27-38. PubMed ID: 30208508
[TBL] [Abstract][Full Text] [Related]
20. Anti-Ro in Sjögren's syndrome and systemic lupus erythematosus.
Harley JB; Scofield RH; Reichlin M
Rheum Dis Clin North Am; 1992 May; 18(2):337-58. PubMed ID: 1626073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
